Anthrogenesis, based in Cedar Knolls, New Jersey, is a biotherapeutics company that has developed proprietary methods for collecting, processing and storing stem cells and other valuable biomaterials derived from human placental tissue. Anthrogenesis is focused on developing and delivering therapies using stem cells sourced from human placental tissue to treat cancers and immunological, metabolic and inflammatory diseases. Anthrogenesis has demonstrated that the human placenta is an abundant source of biotherapies, including early stage stem cells and other biomaterials for organ and tissue repair. Anthrogenesis also operates Lifebank, a state-licensed blood bank that banks stem cell transplant units derived from placental tissue and in some cases, blood from the umbilical cord that is collected immediately after birth.

Celularity, Inc. a clinical stage biotechnology company, which engages in the development of off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer and immune and infectious diseases. It operates through the following segments: Cell Therapy, BioBanking, Degenerative Disease, and Other. The Cell Therapy segment consists of the therapies the company is researching and developing. The BioBanking segment focuses on stem cells from umbilical cords and placentas and provides storage of such cells on behalf of individuals for future use. The Degenerative Disease segment offers products used in surgical and wound care markets. The company was founded by Robert J. Hariri in 2016 and is headquartered in Florham Park, NJ.

National Cancer Center Korea is a South Korean company located in Goyang-si and ultimately controlled by the Government of South Korea. The firm provides clinical and medical research services.

Dongguan Qilizhishang Technology R&D Co., Ltd., established on 2018-09-04, Business scope includes research and development,Sales and technology transfer:Electrical Equipment,smart home appliances,electronic product,Computer hardware and software,General Machinery;Import and export of goods or technology(Except for the import and export of goods and technologies that are prohibited by the state or involve administrative approval).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Tian Qing Stem Cell Co., Ltd. engages in the stem cell extraction and storage services. It is mainly engaged in hematopoietic stem cell storage, umbilical cord mesenchymal stem cell storage, adipose stem cell storage, placental tissue storage and other clinical storage businesses. The company was founded on September 11, 2006 and is headquartered in Harbin, China.

Guangdong General Hospital (Chinese: 广东省人民医院 meaning "Guangdong Provincial People's Hospital") is a large hospital, founded in 1946, located in Yuexiu District, Guangzhou, Guangdong, China.

Guangdong Cardiovascular Institute is a private company headquartered in Guangdong, China, that provides healthcare and surgical services.

Guangzhou Saliai Stemcell Science & Technology Co., Ltd. engages in the provision of stem cell storage, health supplements, biological products, and related health management services. It involves in the production of regenerative medicine devices, medical nutrition supplements, and biological & medical cosmetic products. It operates a research and development platform which includes life bank, health management center, medical center, and medical cell center. The company was founded by Hai Jia Chen and Ming Jia Chen on July 7, 2009 and is headquartered in Guangzhou, China.

Shanxi Stem Cell Genetic Engineering Co., Ltd., established on 2006-03-14, The business scope includes technology development and research of stem cell engineering series products,technology transfer,technical consulting,Technical Information Service.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)***

Huachen Future (Beijing) Biomedical Technology Co., Ltd., established on 2018-09-03, Business scope includes stem cell storage technology services;stem cell biology,cosmetic,medical test,Bioelectronics,Development of immune cell technology,transfer,consult,Serve;Health Advisory(Except for medical treatment activities subject to approval);sell cosmetics,Chemical Products,medical instruments(Class I,Class II).(Market entities independently choose business projects in accordance with the law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Hebei Boyin Biotechnology Co., Ltd., established on 2021-05-17, Business scope includes biotechnology technology development;Cell Technology Development;Human stem cell technology development;Development of Human Gene Diagnosis and Therapy Technology;medical service;Inspection and testing service;Medical beauty service;Beauty and Body Services;Technology intermediary service;medicine,Cosmetic production(limited branch);R&D and production of medical devices and consumables(limited branch);medicine,cosmetic,Sales of medical devices and consumables**(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Hubei Mingde Health Technology Co., Ltd., established on 2018-08-06, The scope of business includes the field of health technology(Excluding vaccines and other special provisions)technology R & D,Technology Promotion,technology transfer,technical consulting,Technical Services;Planting and primary processing of agricultural products,Leisure and sightseeing agriculture(Excluding travel agency business),Import and export business of goods and technology(Except for those restricted or prohibited by the state)chemical reagent(Free of Hazardous Chemicals)Sales,Health Management Services(Does not include diagnosis and treatment),the first sort,Class II medical device,biopharmaceuticals(Does not contain vaccines and other special regulations)research and development,Production,Sales,peripheral blood immune cells,Umbilical cord mesenchymal stem cells,Storage of umbilical cord epithelial stem cells,technical inspection,matching search,Technical Consulting and Technical Services,cosmetic,Research and application of anti-aging stem cell technology and products,Transformation and exchange of achievements;Cosmetic sales,Cell Engineering and Cell Expansion,stem cell,Technology development of immune cells,technology transfer,Technical Advisory Services.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Shandong Qilu Stem Cells Engineering Co. Ltd. operates a cord blood bank. The firm offers stem cell clinical research and technology development, and umbilical cord blood stem cell preservation services. The company was founded in July 2004 and is headquartered in Jinan, China.

Zhejiang Juye Technology Co., Ltd., established on 2014-01-28, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;General equipment manufacturing(Does not include special equipment manufacturing);software sales;software development;Blockchain technology related software and services;Artificial intelligence theory and algorithm software development;sales agent;Security System Monitoring Services;Technology intermediary service;Business Management Consulting;Financial Advisory;Certification Consulting;Indoor Air Pollution Control(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).

CAR-T (Shanghai) Biotech Co., Ltd. engages in the research and development bioengineering, medical, stem cells, and healthcare services. Its business scope includes manufacture of medical devices, hygiene supplies, and disposable medical supplies; and technical development, services, consulting, and technology transfer of therapeutic technology, biotechnology, laboratory equipment technology, and cosmetics technology. The company was founded on December 31, 2015 and is headquartered in Shanghai, China.

Guangdong Messer Cell Biotechnology Co., Ltd., established on 2017-12-19, Business scope includes services:Biological product,Research and development of biomaterials and bioscience technologies,Technical consultation and exchange,Technology promotion and technology transfer services,Stem cell technology research and development,Medical Research and Experimental Development,Storage and Preparation of Stem Cells,Stem Cell Collection and Storage Services(Without umbilical cord blood hematopoietic stem cell collection,storage),Immune cell storage and preparation,Immune cell collection and storage service(Without umbilical cord blood hematopoietic stem cell collection,storage),Stem Cell Drug Technology Research,Food Science and Technology Research,Enterprise Management Services(Excluding investment and asset management),Business Management Consulting;Sales:cosmetic,hygiene products,medical supplies,First,Class II medical device;retail:department store;Production:cosmetic,First,Class II medical device,non-medical masks;Domestic Trade;Import and export of goods or technology(Except for the import and export of goods and technologies that are prohibited by the state or involve administrative approval).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Part of University of Arkansas System, Board of Trustees of The University of Arkansas is a company headquartered in Fayetteville, AR, that owns and operates radio stations.

Americord Registry specializes in umbilical cord blood, cord tissue, and placenta stem cell banking. As a private bank, Americord collects, processes, and stores stem cells for future medical or therapeutic use by the family who saves them. Based in New York, Americord is registered with the FDA and operates in all 50 states. The company’s laboratory is CLIA Certified, accredited by the AABB and complies with all federal and state guidelines and applicable licenses. Founded in 2008, Americord is consistently ranked in Inc Magazine's 5000 fastest growing companies in US since 2015.

Designed Cells Co. Ltd. develops incurable disease cell therapy. The company was founded in 2016 and is headquartered in Cheongju-si, Sourh Korea.